Gene · 7357
Papers2,116
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,116
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clonorchis sinensis infection induces hepatobiliary injury via disturbing sphingolipid metabolism and activating sphingosine 1-phosphate receptor 2. | Front Cell Infect Microbiol | 2022 | 36339341 | PubTator, text mining | PubMed |
| The nutritional functions of dietary sphingomyelin and its applications in food. | Front Nutr | 2022 | 36337644 | PubTator, text mining | PubMed |
| Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients. | Front Immunol | 2022 | 36300104 | PubTator, text mining | PubMed |
| ATP-Binding Cassette Transporter Family C Protein 10 Participates in the Synthesis and Efflux of Hexosylceramides in Liver Cells. | Nutrients | 2022 | 36297086 | PubTator, text mining | PubMed |
| Serum Metabolomics Profiling Reveals Metabolic Alterations Prior to a Diagnosis with Non-Small Cell Lung Cancer among Chinese Community Residents: A Prospective Nested Case-Control Study. | Metabolites | 2022 | 36295809 | PubTator, text mining | PubMed |
| Molecular Classification of Genes Associated with Hypoxic Lipid Metabolism in Pancreatic Cancer. | Biomolecules | 2022 | 36291742 | PubTator, text mining | PubMed |
| High DAPK1 Expression Promotes Tumor Metastasis of Gastric Cancer. | Biology (Basel) | 2022 | 36290392 | PubTator, text mining | PubMed |
| Emerging Roles of Ceramides in Breast Cancer Biology and Therapy. | Int J Mol Sci | 2022 | 36232480 | PubTator, text mining | PubMed |
| The STAGED-PKD 2-Stage Adaptive Study With a Patient Enrichment Strategy and Treatment Effect Modeling for Improved Study Design Efficiency in Patients With ADPKD. | Kidney Med | 2022 | 36204243 | PubTator, text mining | PubMed |
| Dysregulated DNA methylation in the pathogenesis of Fabry disease. | Mol Genet Metab Rep | 2022 | 36186841 | PubTator, text mining | PubMed |
| How sphingolipids affect T cells in the resolution of inflammation. | Front Pharmacol | 2022 | 36176439 | PubTator, text mining | PubMed |
| Dihydroceramide desaturase 1 (DES1) promotes anchorage-independent survival downstream of HER2-driven glucose uptake and metabolism. | FASEB J | 2022 | 36165222 | PubTator, text mining | PubMed |
| Juvenile mucopolysaccharidosis plus disease caused by a missense mutation in VPS33A. | Hum Mutat | 2022 | 36153662 | PubTator, text mining | PubMed |
| The Role of Sphingomyelin and Ceramide in Motor Neuron Diseases. | J Pers Med | 2022 | 36143200 | PubTator, text mining | PubMed |
| Serum Phospholipid Profile Changes in Gaucher Disease and Parkinson's Disease. | Int J Mol Sci | 2022 | 36142296 | PubTator, text mining | PubMed |
| Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells. | Cancers (Basel) | 2022 | 36139656 | PubTator, text mining | PubMed |
| Identification of signature of gene expression in biliary atresia using weighted gene co-expression network analysis. | Medicine (Baltimore) | 2022 | 36123893 | PubTator, text mining | PubMed |
| Roles and therapeutic potential of CD1d-Restricted NKT cells in inflammatory skin diseases. | Front Immunol | 2022 | 36119077 | PubTator, text mining | PubMed |
| Single-cell analysis of gene expression in the substantia nigra pars compacta of a pesticide-induced mouse model of Parkinson's disease. | Transl Neurosci | 2022 | 36117858 | PubTator, text mining | PubMed |
| Pathogenic variants of sphingomyelin synthase SMS2 disrupt lipid landscapes in the secretory pathway. | Elife | 2022 | 36102623 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7357/papers?page=17